XML 70 R76.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Earnings (Loss) Per Share and Stock Repurchase Program - Schedule of EPS (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Numerator for EPS - continuing operations                      
Income from continuing operations $ 32.0 $ 60.0 $ 84.6 $ 154.4 $ 127.6 $ 185.8 $ 87.5 $ (17.3) $ 331.0 $ 383.6 $ 328.5
Less: Income from continuing operations attributed to non-controlling interest 5.3       5.8       25.6 26.7 33.8
Income from continuing operations attributable to Delek (numerator for basic EPS - continuing operations attributable to Delek) 26.7       121.8       305.4 356.9 294.7
Interest on convertible debt, net of tax 0.0       0.0       0.0 2.6 0.0
Numerator for diluted EPS - continuing operations attributable to Delek                 305.4 359.5 294.7
Numerator for EPS - discontinued operations                      
Income (loss) from discontinued operations, including gain (loss) on sale of discontinued operations                 6.6 (10.9) (8.6)
Income tax expense (benefit)                 1.4 (2.2) (2.7)
Income (loss) from discontinued operations, net of tax $ 6.0       $ (0.2)       5.2 (8.7) (5.9)
Less: Income from discontinued operations attributed to non-controlling interest                 0.0 8.1 0.0
Income (loss) from discontinued operations attributable to Delek                 $ 5.2 $ (16.8) $ (5.9)
Denominator:                      
Weighted average common shares outstanding (in shares) 74,042,343       81,321,240       75,853,187 82,797,110 71,566,225
Dilutive effect of convertible debt (in shares)                 0 1,525,846 0
Dilutive effect of warrants (in shares) 0       260,838       0 967,352 0
Dilutive effect of stock-based awards (in shares) 658,583       946,261       720,904 1,478,093 736,858
Weighted average common shares outstanding, assuming dilution (in shares) 74,700,926       82,528,339       76,574,091 86,768,401 72,303,083
Basic income (loss) per share:                      
Income (loss) from continuing operations (USD per share) $ 0.36 $ 0.68 $ 1.02 $ 1.92 $ 1.50 $ 2.15 $ 0.95 $ (0.29) $ 4.03 $ 4.31 $ 4.12
(Loss) income from discontinued operations (USD per share) 0.08       0       0.07 (0.20) (0.08)
Total basic income (loss) per share (USD per share) 0.44       1.50       4.10 4.11 4.04
Diluted income (loss) per share:                      
Income (loss) from continuing operations (USD per share) 0.36 $ 0.68 $ 1.01 $ 1.90 1.48 $ 2.02 $ 0.90 $ (0.29) 3.99 4.14 4.08
(Loss) income from discontinued operations (USD per share) 0.08       0       0.07 (0.19) (0.08)
Total diluted income (loss) per share (USD per share) $ 0.44       $ 1.48       $ 4.06 $ 3.95 $ 4.00
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from computation of earnings per share (in shares) 1,925,207       1,749,569            
Antidilutive stock-based compensation (because average share price is less than exercise price)                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from computation of earnings per share (in shares)                 1,932,179 1,462,112 4,080,723
Antidilutive due to loss                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from computation of earnings per share (in shares)                 0 0 0
Total antidilutive stock-based compensation                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from computation of earnings per share (in shares)                 1,932,179 1,462,112 4,080,723
Antidilutive convertible debt instruments (because average share price is less than exercise price)                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from computation of earnings per share (in shares)                 0 0 2,811,652
Total antidilutive convertible debt instruments                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from computation of earnings per share (in shares)                 0 0 2,811,652
Antidilutive warrants (because average share price is less than exercise price)                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from computation of earnings per share (in shares)                 0 0 2,806,291
Total antidilutive warrants                      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Antidilutive securities excluded from computation of earnings per share (in shares)                 0 0 2,806,291